BI 2536

Catalog No.S1109

BI2536 is a potent Plk1 inhibitor with IC50 of 0.83 nM in a cell-free assay. It shows 4- and 11-fold greater selectivity against Plk2 and Plk3. Phase 2.

Price Stock Quantity  
USD 240 In stock
USD 120 In stock
USD 210 In stock
USD 670 In stock
USD 997 In stock
Bulk Inquiry

Massive Discount Available

Free Overnight Delivery on all orders over $ 500.

BI 2536 Chemical Structure

BI 2536 Chemical Structure
Molecular Weight: 521.66

Validation & Quality Control

Cited by 51 publications:

10 customer reviews :

Quality Control & MSDS

Related Compound Libraries

PLK Inhibitors with Unique Features

  • Selective Plk Inhibitors

    GSK461364 Plk1-selective, Ki=2.2 nM.

  • Plk Inhibitor in Clinical Trial

    Rigosertib (ON-01910) Phase III for Myelo Dysplastic Syndrome (MDS).

  • Newest Plk Inhibitor

    Ro3280 Potent, highly selective inhibitor of Polo-like kinase 1 (PLK1) with IC50 of 3 nM.

  • Calssic Plk Inhibitor

    Volasertib (BI 6727) Highly potent Plk1 inhibitor with IC50 of 0.87 nM and in phase II trials.

Product Information

  • Compare PLK Inhibitors
    Compare PLK Products
  • Research Area
  • Inhibition Profile
  • BI 2536 Mechanism

Product Description

Biological Activity

Description BI2536 is a potent Plk1 inhibitor with IC50 of 0.83 nM in a cell-free assay. It shows 4- and 11-fold greater selectivity against Plk2 and Plk3. Phase 2.
Targets PLK1 [1]
(Cell-free assay)
PLK2 [1]
(Cell-free assay)
PLK3 [1]
(Cell-free assay)
PI3Kα [1]
(Cell-free assay)

 View  More

IC50 0.83 nM 3.5 nM 9.0 nM 2.407 μM
In vitro BI 2536 blocks the activities of Plk2 and Plk3 to a slightly lesser extent with IC50 of 3.5 nM and 9.0 nM, respectively. In HeLa cells, BI 2536 treatment ranging from 10-100 nM leads to the blocking of the recruitment of γ-tubulin and phosphorylation of Apc6 at mitotic centrosomes, inhibition of cohesin release from chromosome arms, induction of monopolar spindles, as well as a range of other mitotic processes that are known to depend on Plk1. BI 2536 treatment leads to the HeLa cells arrested in G2/M, subsequently a sub-G1 DNA peak indicative of DNA breakdown and apoptosis, and accumulated cleaved PARP p85 fragments in a concentration-dependent manner. BI 2536 inhibits the growth of a panel of 32 human cancer cell lines with EC50 of 2-25 nM, while blocking the proliferation of exponentially growing hTERT-RPE1, human umbilical vein endothelial cells (HUVECs), and normal rat kidney (NRK) cells with EC50 of 12-31 nM. [1] Plk1 inhibition by BI 2536 reduces the growth and viability of anaplastic thyroid carcinoma (ATC) cells such as CAL62, OCUT-1, SW1736, 8505C, and ACT-1 with EC50 values of 1.4-5.6 nM. [2]
Cell Data
Cell LinesAssay TypeConcentrationIncubation TimeFormulationActivity DescriptionPMID
PSN1M2XWcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYLJR|UxRTBwMEC3O|Yh|ryPMkH2V2FPT0WU
ACNNWm1[pczT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnH0TWM2OD1yLkCwPFQ{KM7:TR?=MlrzV2FPT0WU
TE-8MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mn7LTWM2OD1yLkCwPVQyKM7:TR?=NHfW[3RUSU6JRWK=
LC-2-adMWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MU\JR|UxRTBwMEGwPVMh|ryPMmXZV2FPT0WU
ALL-PONYDlSpk3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{H1b2lEPTB;MD6wNVMh|ryPMWnTRW5ITVJ?
EW-16NGi3VZRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVTJR|UxRTBwMEGzN|Yh|ryPNF7NR4tUSU6JRWK=
KM12MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlzyTWM2OD1yLkCxN|Q5KM7:TR?=NWrLW5JYW0GQR1XS
GI-1NGD6bJdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3HLXmlEPTB;MD6wNVM5OyEQvF2=MoPKV2FPT0WU
LS-411NMWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlPzTWM2OD1yLkCxOFA4KM7:TR?=NVPkdmdSW0GQR1XS
ES8Ml;YS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUTPTGp3UUN3ME2wMlAyPDl2IN88US=>NWXWUWFFW0GQR1XS
SNU-C2BNUXCOoY6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFHucpBKSzVyPUCuNFE2OjZizszNMULTRW5ITVJ?
CESSM{fRSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1m5OmlEPTB;MD6wNVYxOiEQvF2=NXLldXhlW0GQR1XS
697MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3PIVmlEPTB;MD6wNVY3QCEQvF2=NEfKUIxUSU6JRWK=
NCI-H1963M4jJPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUSxbVBpUUN3ME2wMlAyPjd|IN88US=>NX3CdVljW0GQR1XS
IA-LMM{eyZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUfJR|UxRTBwMEG2PFgh|ryPNGjB[olUSU6JRWK=
SW954Mmm2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVLJR|UxRTBwMEG3NFUh|ryPMWLTRW5ITVJ?
RL95-2NHPNd2hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUTJR|UxRTBwMEG3N|gh|ryPM3\jdXNCVkeHUh?=
LXF-289NHvnVWRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYjmfZZDUUN3ME2wMlAyPzdizszNM{fYTXNCVkeHUh?=
OCUB-MMnzRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoPmTWM2OD1yLkCxPFI3KM7:TR?=M{W0cHNCVkeHUh?=
RKOMWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnrwTWM2OD1yLkCxPVg4KM7:TR?=MYfTRW5ITVJ?
LOUCYNX3WR5I3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mnn2TWM2OD1yLkCyNFUh|ryPM2jWeHNCVkeHUh?=
NOS-1MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M33CWmlEPTB;MD6wNlA6OyEQvF2=NX7BdJRNW0GQR1XS
A4-FukNUTSSWlCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkT5TWM2OD1yLkCyNlE5KM7:TR?=M{LaXnNCVkeHUh?=
A388NHzQT5pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIfacmtKSzVyPUCuNFIzOjdizszNNGDhUlFUSU6JRWK=
TE-9MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYXJR|UxRTBwMEKyOlEh|ryPM{XhOHNCVkeHUh?=
KURAMOCHINFr1d4FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVf3U4lXUUN3ME2wMlAzOjh3IN88US=>MX3TRW5ITVJ?
KALS-1NUf4ZppKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NULqSpVGUUN3ME2wMlAzOzN6IN88US=>M3nxZnNCVkeHUh?=
HOP-62M1exRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4Dzb2lEPTB;MD6wNlQzKM7:TR?=NFfhT49USU6JRWK=
RPMI-8402NFfKcmtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{PiUWlEPTB;MD6wNlUxQCEQvF2=M4fMTnNCVkeHUh?=
TE-1NI\N[YJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUTJR|UxRTBwMEK1NVIh|ryPMYDTRW5ITVJ?
CCRF-CEMNFToUIFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGLOe5VKSzVyPUCuNFI2PDNizszNNFzPWWRUSU6JRWK=
HUTU-80Mm\1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGTDSpFKSzVyPUCuNFI3OjRizszNMnvjV2FPT0WU
NCI-H1648NHXQPVFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVjJR|UxRTBwMEK2OFch|ryPMWfTRW5ITVJ?
HCE-4NVLje5JuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGj6NoxKSzVyPUCuNFI3QDJizszNNXHlTHRVW0GQR1XS
ETK-1MmHXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmrCTWM2OD1yLkCyO|M3KM7:TR?=MXnTRW5ITVJ?
TE-15NXfhSFh4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlnvTWM2OD1yLkCyO|M5KM7:TR?=NVfrOZNTW0GQR1XS
BE-13M1LQ[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Ml\jTWM2OD1yLkCyO|Qh|ryPNFjyUJdUSU6JRWK=
KE-37MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NETsZ3ZKSzVyPUCuNFI4PDFizszNNEDUTFZUSU6JRWK=
NCI-H1355NW\nRoMyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWnJR|UxRTBwMEK3PFMh|ryPMkHpV2FPT0WU
TE-11NV3ESVBST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVzJR|UxRTBwMEK4NFkh|ryPMV3TRW5ITVJ?
BL-70M1riVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXTJR|UxRTBwMEK4OVch|ryPM4DjZnNCVkeHUh?=
ES6MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmTQTWM2OD1yLkCyPFgyKM7:TR?=MlzFV2FPT0WU
GT3TKBM3T0NGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFPwUppKSzVyPUCuNFI6PTNizszNMnO1V2FPT0WU
LB647-SCLCNVq0[Y9nT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWTQUpo1UUN3ME2wMlA{OTl3IN88US=>MnLFV2FPT0WU
NB13NELmSWxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWnJR|UxRTBwMEOzNVYh|ryPNHjnXVVUSU6JRWK=
ST486NYDIemxRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWfJR|UxRTBwMEOzN|ch|ryPMlz6V2FPT0WU
NCI-H82M{\l[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mlj2TWM2OD1yLkCzN|Q{KM7:TR?=NIOwXlhUSU6JRWK=
NTERA-S-cl-D1NEj3W3VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkC3TWM2OD1yLkCzN|k6KM7:TR?=MnHBV2FPT0WU
ES4MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWDJR|UxRTBwMEO0OlMh|ryPNGnHXJBUSU6JRWK=
SK-NEP-1M4DzVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWfiWlQ3UUN3ME2wMlA{PDl7IN88US=>MkHYV2FPT0WU
BeckerMVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkniTWM2OD1yLkCzOVU2KM7:TR?=NEHDc2VUSU6JRWK=
A101DNYnae|RxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2q4VWlEPTB;MD6wN|c1QCEQvF2=NEC0U5VUSU6JRWK=
SK-UT-1M3TVbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NH7SPFlKSzVyPUCuNFM4PzRizszNMmj3V2FPT0WU
SW982NFm2SYRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2\CbWlEPTB;MD6wN|c6KM7:TR?=MnfOV2FPT0WU
TE-10M3zvZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXnkemE1UUN3ME2wMlA1ODR4IN88US=>NYfSTmY4W0GQR1XS
OVCAR-4M1PWR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MliwTWM2OD1yLkC0NFU6KM7:TR?=NFzXVHdUSU6JRWK=
KP-N-YSMWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MULJR|UxRTBwMESwPFUh|ryPMUDTRW5ITVJ?
BL-41MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2HzWGlEPTB;MD6wOFEzPSEQvF2=MYTTRW5ITVJ?
MZ1-PCMULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2fC[GlEPTB;MD6wOFEzPyEQvF2=NFLMZW1USU6JRWK=
PF-382NG[zRZdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MV3JR|UxRTBwMESxPVgh|ryPMmPaV2FPT0WU
MOLT-13MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXLDc4sxUUN3ME2wMlA1OjN6IN88US=>NYnvUW43W0GQR1XS
HCC1599NFjuSVNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWjCc4ZQUUN3ME2wMlA1OjV6IN88US=>NVjCfWdyW0GQR1XS
IST-MEL1MmnVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIe2UGlKSzVyPUCuNFQ1PDJizszNMX7TRW5ITVJ?
LU-139M3zxc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUj1dmU{UUN3ME2wMlA1PDR{IN88US=>MU\TRW5ITVJ?
MS-1NF;VbGlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmDETWM2OD1yLkC0O|AyKM7:TR?=MXLTRW5ITVJ?
MFH-inoMlmxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkH2TWM2OD1yLkC1NFA{KM7:TR?=M4DhR3NCVkeHUh?=
IMR-5MmfuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlXaTWM2OD1yLkC1NFIyKM7:TR?=NFXRO25USU6JRWK=
TE-5M{LiTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEH1cmZKSzVyPUCuNFUxPjNizszNMVvTRW5ITVJ?
DJM-1MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFW4VYJKSzVyPUCuNFUyPDJizszNMmTRV2FPT0WU
NB17MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mn\tTWM2OD1yLkC1NlA4KM7:TR?=M2TvXXNCVkeHUh?=
KARPAS-45M{fDbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWOyeG9HUUN3ME2wMlA2OzV6IN88US=>M{jTRXNCVkeHUh?=
TGBC1TKBNUmxc4lVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlPoTWM2OD1yLkC1OFA2KM7:TR?=M3TNTHNCVkeHUh?=
ML-2MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmLmTWM2OD1yLkC1OFE1KM7:TR?=NHuwRZlUSU6JRWK=
no-10MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mn;uTWM2OD1yLkC1OFc1KM7:TR?=M1:xO3NCVkeHUh?=
CTV-1M17UUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEPPUFJKSzVyPUCuNFU2ODJizszNMXfTRW5ITVJ?
SJSA-1MoLES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NI[zbXBKSzVyPUCuNFU2OiEQvF2=NFjofJpUSU6JRWK=
HC-1NYjpToNST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mo\oTWM2OD1yLkC1OVk4KM7:TR?=MUHTRW5ITVJ?
TE-12M4Tp[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{fOc2lEPTB;MD6wOVYyOyEQvF2=MkDRV2FPT0WU
KY821MmnwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mk[zTWM2OD1yLkC1OlMzKM7:TR?=MXvTRW5ITVJ?
TALL-1M4n6Smdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2fyRmlEPTB;MD6wOVcxQCEQvF2=NWHtO3BjW0GQR1XS
DELMYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{\6TmlEPTB;MD6wOVcxQSEQvF2=MWnTRW5ITVJ?
TE-6NVz1Rm9QT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1TycmlEPTB;MD6wOVczOiEQvF2=MlfyV2FPT0WU
SK-LMS-1MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1\w[mlEPTB;MD6wOVgxPSEQvF2=NYT5OWREW0GQR1XS
EW-1MkW0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGLlVZNKSzVyPUCuNFU5OzdizszNNXWwdHV7W0GQR1XS
8-MG-BANVj1UGdZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYjBfnR5UUN3ME2wMlA2QDVzIN88US=>NFu5TWhUSU6JRWK=
NALM-6NHO4VYZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXe4[FVQUUN3ME2wMlA2QTd|IN88US=>NUS3[ph5W0GQR1XS
LB771-HNCMYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnrDTWM2OD1yLkC1PVc6KM7:TR?=M4fNSnNCVkeHUh?=
HT-144M2DTZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHrFSZNKSzVyPUCuNFYyOyEQvF2=MWnTRW5ITVJ?
KM-H2M3PaR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NX\XeJc{UUN3ME2wMlA3OjJzIN88US=>NGHGbI9USU6JRWK=
SF268NYHq[GU3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnXYTWM2OD1yLkC2Nlg3KM7:TR?=M1PqVXNCVkeHUh?=
RS4-11NIDwbZFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MoHBTWM2OD1yLkC2N|A1KM7:TR?=MYLTRW5ITVJ?
MHH-PREB-1Moj1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUPreVZMUUN3ME2wMlA3OzF7IN88US=>Mn;VV2FPT0WU
ATN-1MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYTXUVJkUUN3ME2wMlA3OzR3IN88US=>NHHrU2NUSU6JRWK=
BB30-HNCM2fPUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYrtS4p5UUN3ME2wMlA3PDN4IN88US=>MUjTRW5ITVJ?
CPC-NMY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYXzdI16UUN3ME2wMlA3PTJ2IN88US=>MWDTRW5ITVJ?
NB1NYrK[nhnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1zsZmlEPTB;MD6wOlYyOyEQvF2=NEjs[YJUSU6JRWK=
KS-1NUKzcGNCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVXJR|UxRTBwME[3OFgh|ryPMXrTRW5ITVJ?
RXF393M3HuZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIrrb49KSzVyPUCuNFY4PjRizszNM162S3NCVkeHUh?=
IST-SL2NYq1cWxUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MV7JR|UxRTBwMEewNFQh|ryPMkHYV2FPT0WU
GI-ME-NM1S3cWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3;m[mlEPTB;MD6wO|I5PiEQvF2=NYCxbIRQW0GQR1XS
VA-ES-BJNHTHc|VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3rJZWlEPTB;MD6wO|Q4PSEQvF2=MYHTRW5ITVJ?
NCI-H1581MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3XXdmlEPTB;MD6wO|Q4QCEQvF2=NYjZRVRtW0GQR1XS
U-266MnPwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3G2UWlEPTB;MD6wO|Q6PyEQvF2=M3u5bHNCVkeHUh?=
DMS-114M3;Tfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGHIOJRKSzVyPUCuNFc2OjhizszNMV3TRW5ITVJ?
NCI-H187MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFeyW3NKSzVyPUCuNFc4OjZizszNNU\rWnpOW0GQR1XS
SW962MlfqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M360UWlEPTB;MD6wO|g{QSEQvF2=MnXVV2FPT0WU
MONO-MAC-6Mn3lS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHLUc5VKSzVyPUCuNFc6QDZizszNNUW5SphxW0GQR1XS
MOLT-16MnjPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVnyVIgxUUN3ME2wMlA5OTJzIN88US=>M{Pzb3NCVkeHUh?=
KNS-42NV\3fHh7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHK3UolKSzVyPUCuNFgyPjFizszNNFGycWxUSU6JRWK=
CMKMXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NEL6b3FKSzVyPUCuNFgzOjVizszNNGnVeXlUSU6JRWK=
Ramos-2G6-4C10NHfrWFZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEmwcJpKSzVyPUCuNFgzOjVizszNM1XFVHNCVkeHUh?=
DaudiMWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmfETWM2OD1yLkC4NlU3KM7:TR?=M{D1b3NCVkeHUh?=
NCI-H510AM1P5R2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1vMZmlEPTB;MD6wPFM{PiEQvF2=MWrTRW5ITVJ?
LB831-BLCNYrkbHNjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUi5XWpGUUN3ME2wMlA5PTZzIN88US=>NHm3fJRUSU6JRWK=
HELNGHD[IpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3HsRmlEPTB;MD6wPFY3QCEQvF2=MnjKV2FPT0WU
LU-134-ANFn0ZmlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWjRfHRHUUN3ME2wMlA5PzB6IN88US=>MX7TRW5ITVJ?
NCI-H1694MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1jUV2lEPTB;MD6wPFc1PCEQvF2=NGHDZ4RUSU6JRWK=
KGNMnXoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmO0TWM2OD1yLkC4O|U6KM7:TR?=NFzVboFUSU6JRWK=
A253NHTzXJFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFzlZXhKSzVyPUCuNFg5OjJizszNM3ixbXNCVkeHUh?=
DG-75M3PHUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3\w[GlEPTB;MD6wPFkzOiEQvF2=MkK5V2FPT0WU
MOLT-4MofES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmGzTWM2OD1yLkC4PVg{KM7:TR?=NITZbHRUSU6JRWK=
NCI-SNU-5M3z4[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVrJR|UxRTBwMEmyOVgh|ryPMV\TRW5ITVJ?
ONS-76MmHiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWX3ZndWUUN3ME2wMlA6Ojd4IN88US=>MlniV2FPT0WU
NCI-H446MojWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEPwd3hKSzVyPUCuNFk1PjJizszNMWrTRW5ITVJ?
COR-L279MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1y2NmlEPTB;MD6wPVU2PiEQvF2=MnXlV2FPT0WU
Calu-6MoGwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVHJR|UxRTBwMEm1PVgh|ryPMm\nV2FPT0WU
BC-3M4K1PGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYniPGVKUUN3ME2wMlA6PjZ{IN88US=>M4Lqc3NCVkeHUh?=
NCI-H2126MoHCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFvOSHpKSzVyPUCuNFk4QTFizszNMXvTRW5ITVJ?
NCI-H1882NWDZSGdWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFK4XGdKSzVyPUCuNFk5ODlizszNMXTTRW5ITVJ?
BB65-RCCNU\CUItrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYjsWJRZUUN3ME2wMlExOjl2IN88US=>MXXTRW5ITVJ?
DU-4475M4m3Xmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHznSHpKSzVyPUCuNVA1ODdizszNMYPTRW5ITVJ?
NCI-H526MoLRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MknMTWM2OD1yLkGwOFQh|ryPNEP2SnhUSU6JRWK=
NEC8NXfHRVdWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlHDTWM2OD1yLkGwOVI2KM7:TR?=MlnYV2FPT0WU
NCI-H1304NYnEeYJxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYH1T4F2UUN3ME2wMlExPTl2IN88US=>NGX6TmdUSU6JRWK=
L-540MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4K5VmlEPTB;MD6xNFcxQCEQvF2=MVPTRW5ITVJ?
NCI-SNU-16NWnGVmttT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4TkWWlEPTB;MD6xNFc1OiEQvF2=M{LlenNCVkeHUh?=
HD-MY-ZMVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYXhNZg5UUN3ME2wMlExQDV4IN88US=>NXzON5NjW0GQR1XS
K-562M2O3PWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NX;0[oNjUUN3ME2wMlExQDV6IN88US=>MkXTV2FPT0WU
JARM1HTWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NU\0WGtlUUN3ME2wMlExQTJ3IN88US=>M1jCeHNCVkeHUh?=
MZ2-MELMlvJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVXJR|UxRTBwMUGwOUDPxE1?M4rRXXNCVkeHUh?=
L-363NU\ubJVCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3vOZmlEPTB;MD6xNVA4QSEQvF2=M1XaenNCVkeHUh?=
BV-173NV32dVhPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4joeGlEPTB;MD6xNVI1OyEQvF2=MUPTRW5ITVJ?
NCI-H524NVWwZ4N3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXLJR|UxRTBwMUGyO|Qh|ryPNXrjUJlNW0GQR1XS
EoL-1-cellNV\p[JZWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlvITWM2OD1yLkGxOlczKM7:TR?=NWSz[2drW0GQR1XS
K052M3XYd2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUfJR|UxRTBwMUG3NVIh|ryPNGPxW2VUSU6JRWK=
TK10MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmnXTWM2OD1yLkGxO|I5KM7:TR?=MknGV2FPT0WU
KU812M{H5XWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoPVTWM2OD1yLkGyNFQ1KM7:TR?=MXfTRW5ITVJ?
RPMI-8226NGDzbnhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXjYeFRpUUN3ME2wMlEzODV{IN88US=>NYjiVpNCW0GQR1XS
MZ7-melMnTzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2DKOmlEPTB;MD6xNlI{PyEQvF2=M{LsO3NCVkeHUh?=
SK-PN-DWNHnpRoZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NInnNHNKSzVyPUCuNVIzQDdizszNMWjTRW5ITVJ?
SRM3nXSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVrJR|UxRTBwMUK0OFEh|ryPM{\3c3NCVkeHUh?=
RPMI-6666MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2DLfGlEPTB;MD6xNlc1OyEQvF2=NGnsOVZUSU6JRWK=
no-11NF;y[3hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYr5fHJoUUN3ME2wMlEzQDZ7IN88US=>MU\TRW5ITVJ?
EW-3NHezbXBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3nvVmlEPTB;MD6xNlg6OyEQvF2=NGOwTodUSU6JRWK=
LAMA-84MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnnuTWM2OD1yLkGzNVg4KM7:TR?=NX3n[Wh7W0GQR1XS
HTMUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnTQTWM2OD1yLkGzOVc1KM7:TR?=MlfGV2FPT0WU
KP-N-RT-BM-1NVPXVFAxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3LiRmlEPTB;MD6xN|YyOiEQvF2=NEfnZ4NUSU6JRWK=
NCI-H747M{jNZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWjJR|UxRTBwMUO3JO69VQ>?MX3TRW5ITVJ?
NCCITNHHBN2FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MorVTWM2OD1yLkGzPVM6KM7:TR?=Mn3vV2FPT0WU
MLMANYLHe4JST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MojOTWM2OD1yLkG0NVY4KM7:TR?=M3XPUHNCVkeHUh?=
LP-1Mom5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NX7qd|RMUUN3ME2wMlE1OjRizszNNULVfpY3W0GQR1XS
CAL-148M{K0VWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoCyTWM2OD1yLkG0OFg{KM7:TR?=MljNV2FPT0WU
GB-1M3\JTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVjJR|UxRTBwMUS1NlYh|ryPNIHGbo1USU6JRWK=
COR-L88M{fnWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3TsT2lEPTB;MD6xOFgxOiEQvF2=MkXRV2FPT0WU
NKM-1NYPISHlIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWTPdZdrUUN3ME2wMlE1QTB4IN88US=>NIG0UJJUSU6JRWK=
NB5MlzqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWHB[nVqUUN3ME2wMlE2PDZ{IN88US=>MojYV2FPT0WU
SH-4M4PyV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUPJR|UxRTBwMUW0OlYh|ryPMonaV2FPT0WU
EM-2M4XPNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYLjfmN3UUN3ME2wMlE2PDZ5IN88US=>NIr5O5BUSU6JRWK=
TGBC24TKBM1The2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4Pv[WlEPTB;MD6xOVY2QSEQvF2=NVzaTmZkW0GQR1XS
SCLC-21HMl;vS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4PsTGlEPTB;MD6xOVcxOiEQvF2=MWfTRW5ITVJ?
COLO-684MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGPRfYxKSzVyPUCuNVU4OjFizszNMnjIV2FPT0WU
KINGS-1MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXKySJo1UUN3ME2wMlE2QTFizszNM3\6bHNCVkeHUh?=
LS-123M3S2cmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUDxV2NYUUN3ME2wMlE2QTF5IN88US=>M4m5N3NCVkeHUh?=
MC116NFzSbY1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHHIelRKSzVyPUCuNVYyPThizszNMkjCV2FPT0WU
SU-DHL-1NEDhb2dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3LUR2lEPTB;MD6xOlIxPiEQvF2=NIPT[49USU6JRWK=
NCI-H64M{XBRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2\mTmlEPTB;MD6xOlM1PyEQvF2=Mn\CV2FPT0WU
HCE-TMXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYjmfXNsUUN3ME2wMlE3PTB2IN88US=>MUXTRW5ITVJ?
LOXIMVIMYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYnmc5FyUUN3ME2wMlE3QTR7IN88US=>MonHV2FPT0WU
ARH-77MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mn7vTWM2OD1yLkG3N|c6KM7:TR?=NYTOO4luW0GQR1XS
DOHH-2MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{j2cmlEPTB;MD6xO|Y4OiEQvF2=M3fBWXNCVkeHUh?=
COLO-320-HSRMYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2Oz[2lEPTB;MD6xPFE2PCEQvF2=M{L1Z3NCVkeHUh?=
NB6NVO4NFQxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1fFR2lEPTB;MD6xPFU3PiEQvF2=NFPtUoNUSU6JRWK=
L-428NIDlTI5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NF3uO2JKSzVyPUCuNVg5OTNizszNNX25SY1lW0GQR1XS
SNB75NG\YboxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3PqOmlEPTB;MD6xPFgzPCEQvF2=NF3VdmZUSU6JRWK=
NCI-H2141NGLKTG1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{fYWGlEPTB;MD6xPVAyOSEQvF2=MnnyV2FPT0WU
KARPAS-299Mn:wS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3;CZ2lEPTB;MD6xPVI1OSEQvF2=NF6zdnNUSU6JRWK=
LC4-1M1HJeWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NE[3PWhKSzVyPUCuNVk2ODJizszNNXPZZoFOW0GQR1XS
UACC-257Ml3qS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVL4SmVMUUN3ME2wMlE6QTR5IN88US=>NHfpZ|JUSU6JRWK=
EVSA-TMkflS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlflTWM2OD1yLkKwN|EzKM7:TR?=NUDZU|hLW0GQR1XS
JiyoyeP-2003MoXnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NF3LbHBKSzVyPUCuNlA1PzdizszNM{TM[HNCVkeHUh?=
NCI-H720MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUXBXlNEUUN3ME2wMlIxPTJ3IN88US=>MX;TRW5ITVJ?
GAKMXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MX7JR|UxRTBwMkGxPFkh|ryPNED4O5RUSU6JRWK=
HHMWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWmxfWpUUUN3ME2wMlIyPDB3IN88US=>MmmzV2FPT0WU
NCI-H1436MkDHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2SyOGlEPTB;MD6yNVQ3PCEQvF2=MWLTRW5ITVJ?
GR-STNE\zbpFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mn7YTWM2OD1yLkKxOFg5KM7:TR?=NHG1SmVUSU6JRWK=
BC-1MonVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MV;JR|UxRTBwMkK2NVYh|ryPMnLZV2FPT0WU
SIG-M5NEXneI1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGHPem5KSzVyPUCuNlI4OjdizszNMoe3V2FPT0WU
NCI-H345NVjLPIhoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NX\LVlR5UUN3ME2wMlI{QDB3IN88US=>NFzqbmxUSU6JRWK=
OPM-2NHrTepdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmPkTWM2OD1yLkKzPFgzKM7:TR?=NHKzXXhUSU6JRWK=
LB1047-RCCMlvJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3LNbWlEPTB;MD6yOFQyKM7:TR?=NYD4fXNoW0GQR1XS
CTB-1MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MX3JR|UxRTBwMkS0PVMh|ryPMkTLV2FPT0WU
A3-KAWNWDNfphXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHrzVplKSzVyPUCuNlU{PDFizszNM2njd3NCVkeHUh?=
SF126NUnL[ZNWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUHJR|UxRTBwMkWzPFMh|ryPMX\TRW5ITVJ?
KARPAS-422NFPBTGRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXzJR|UxRTBwMkW0N|Uh|ryPMkHTV2FPT0WU
MEG-01MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3:xSWlEPTB;MD6yOVY4OyEQvF2=MlfzV2FPT0WU
NCI-H209MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{PvXmlEPTB;MD6yOlM4PCEQvF2=NFzBPW5USU6JRWK=
SBC-1MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MY\JR|UxRTBwMk[1JO69VQ>?Mm\PV2FPT0WU
K5MnLlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NImySVNKSzVyPUCuNlY6QDRizszNNVftVnl1W0GQR1XS
QIMR-WILMmG1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3n4[GlEPTB;MD6yO|E2PSEQvF2=M1XiS3NCVkeHUh?=
NMC-G1MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NH7NfYpKSzVyPUCuNlgzOTdizszNNEHXeW9USU6JRWK=
IST-MES1NWPkSnZDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mm\JTWM2OD1yLkK5NlM5KM7:TR?=NEX1O4NUSU6JRWK=
SW684NFrSdW1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NW\mRVZNUUN3ME2wMlMxODR5IN88US=>NUe1N5JxW0GQR1XS
MV-4-11Ml72S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIfqO45KSzVyPUCuN|A4QDhizszNNGjMPJFUSU6JRWK=
LAN-6MlntS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXjFPZRSUUN3ME2wMlMyPTd{IN88US=>M4HFZ3NCVkeHUh?=
RH-1NY\EN3JmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUXvUW5KUUN3ME2wMlMyQDdzIN88US=>MmW2V2FPT0WU
CP66-MELMXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVr3UZVlUUN3ME2wMlMyQDd6IN88US=>MXvTRW5ITVJ?
EC-GI-10M3jQfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{\H[2lEPTB;MD6zNlk5PyEQvF2=NXi4[mJyW0GQR1XS
GDM-1MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoDiTWM2OD1yLkOzNFU6KM7:TR?=MlzLV2FPT0WU
IST-SL1Ml;jS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnnaTWM2OD1yLkO0PVE1KM7:TR?=M2DtenNCVkeHUh?=
KMOE-2NGrHUpJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWXySIZqUUN3ME2wMlM2OTd3IN88US=>MmP0V2FPT0WU
OS-RC-2Mn3RS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3HRS2lEPTB;MD6zOVU1PCEQvF2=NWDJNHo{W0GQR1XS
HDLM-2MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGju[FFKSzVyPUCuN|c5OTRizszNNFriWZNUSU6JRWK=
DSH1MoTLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MojhTWM2OD1yLkO4OlMyKM7:TR?=NEG1e|FUSU6JRWK=
LS-1034MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoXVTWM2OD1yLkO4PVU1KM7:TR?=MYrTRW5ITVJ?
LB373-MEL-DM3juSGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHT4O4JKSzVyPUCuN|kyQTdizszNMWjTRW5ITVJ?
GOTOMYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4XZWWlEPTB;MD60NlEyQCEQvF2=NHv4UlJUSU6JRWK=
MRK-nu-1NI\wTYRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M33ZcGlEPTB;MD60NlIxPSEQvF2=NFzTS29USU6JRWK=
SK-MM-2MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{[y[GlEPTB;MD60N|Q1OiEQvF2=NGDTeZNUSU6JRWK=
BOKUNWPKeZNOT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXXaXnd5UUN3ME2wMlQ{Pzl{IN88US=>MUfTRW5ITVJ?
NOMO-1NEDNRpZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnHKTWM2OD1yLkSzPFYh|ryPNF22T2JUSU6JRWK=
J-RT3-T3-5NHjUb3pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGHCS4dKSzVyPUCuOFQ5PzhizszNNXvQWXVYW0GQR1XS
COLO-668MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3foWWlEPTB;MD60OVY3QCEQvF2=M{S4NnNCVkeHUh?=
SF539MkPTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIrKOINKSzVyPUCuOFg3QDRizszNM4TITnNCVkeHUh?=
LB2518-MELNV3jWpR4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFT2[YpKSzVyPUCuOFk4ODNizszNMmXhV2FPT0WU
TE-441-TMlPJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUPJR|UxRTBwNUCxNkDPxE1?MkC1V2FPT0WU
MDA-MB-134-VIMW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWfyU286UUN3ME2wMlUxQTJzIN88US=>MYLTRW5ITVJ?
SCC-3M2PhRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXzOelRHUUN3ME2wMlUyQDd|IN88US=>NFz6Z|ZUSU6JRWK=
KLEMmPZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mn3nTWM2OD1yLkWyNVcyKM7:TR?=NVnXSYY2W0GQR1XS
LB2241-RCCNGjBTpFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1jPdmlEPTB;MD61NlUzPSEQvF2=MlzOV2FPT0WU
NCI-H1417M4PkZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2XaOWlEPTB;MD61N|Q{PSEQvF2=MWfTRW5ITVJ?
NCI-H2081MmPpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYfJR|UxRTBwNUi2NVEh|ryPMXvTRW5ITVJ?
NCI-H1522M2frW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWTJR|UxRTBwNUmzPFMh|ryPM4qxSnNCVkeHUh?=
NCI-H889M2H6Smdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVPJR|UxRTBwNUm4OFQh|ryPMoryV2FPT0WU
CGTH-W-1MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWDJR|UxRTBwNkC3OVUh|ryPM13FeHNCVkeHUh?=
EB-3MoT0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlzyTWM2OD1yLk[xNVU{KM7:TR?=MkjVV2FPT0WU
D-336MGNUX6RZl4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWfBUXdIUUN3ME2wMlYyPzlzIN88US=>MWXTRW5ITVJ?
LC-1FM1P4eGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1vVWmlEPTB;MD62NlU6OiEQvF2=NXvkbIlNW0GQR1XS
MHH-NB-11MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYTFO5dvUUN3ME2wMlY{QDBzIN88US=>NVzLOXNzW0GQR1XS
SK-N-FIM4fHUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NI\HbWdKSzVyPUCuOlM6OSEQvF2=M2nxeHNCVkeHUh?=
NCI-H69Mn7ZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{XNc2lEPTB;MD62OFg4QSEQvF2=MoS5V2FPT0WU
SCHNUDtW4hoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVTJR|UxRTBwNk[wNlMh|ryPNIXOeW5USU6JRWK=
LS-513MmD4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWHJR|UxRTBwNkeyOVkh|ryPNV7BN3RQW0GQR1XS
CP67-MELMoDZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnrCTWM2OD1yLk[3OVk3KM7:TR?=M3vXbHNCVkeHUh?=
GCIYMkS4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkPtTWM2OD1yLkewN|Y{KM7:TR?=NY\jdGtNW0GQR1XS
SHP-77MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVfJR|UxRTBwN{C3N|Qh|ryPNGTjRVJUSU6JRWK=
EHEBM1WzbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFXUcFdKSzVyPUCuO|E5PTRizszNMl7RV2FPT0WU
D-247MGMkXNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M13W[GlEPTB;MD63N|I{OiEQvF2=MnzUV2FPT0WU
RajiMXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGfwXmNKSzVyPUCuO|Q6QDlizszNNUf0T5pWW0GQR1XS
MPP-89NYC0V4VvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVnsRotzUUN3ME2wMlc2QTd6IN88US=>MUPTRW5ITVJ?
EKVXNIXQU2VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFviSHBKSzVyPUCuO|kxPzNizszNNETIR5VUSU6JRWK=
HCC2218MmHrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NH7zcGNKSzVyPUCuO|kyOzFizszNM3\FUHNCVkeHUh?=
KNS-81-FDMUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWPJR|UxRTBwOEGwNVEh|ryPMnrrV2FPT0WU
HCC2157MnTrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXrONZJyUUN3ME2wMlg1QTVzIN88US=>NFzwOlhUSU6JRWK=
BT-474NI\tfYpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVrzd5hlUUN3ME2wMlg5QDV2IN88US=>M4C5[HNCVkeHUh?=
NCI-H748NGDYO2xIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NITWO3dKSzVyPUCuPVEzKM7:TR?=NH3lOYlUSU6JRWK=
EW-24MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3vHcmlEPTB;MD65NlAxOiEQvF2=NHn2bWtUSU6JRWK=
D-263MGMkPJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXXJR|UxRTBwOUS1NVIh|ryPM3TZZXNCVkeHUh?=
OMC-1NWTyXVBrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUnWfYZTUUN3ME2wMlk3Ozd|IN88US=>NXrUZ4RLW0GQR1XS
NCI-H2196NV6x[IRET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYLwVod5UUN3ME2wMlk4Pzd5IN88US=>NHHFd5BUSU6JRWK=
HAL-01NGW1[|VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFjkOmNKSzVyPUCuPVk5PzJizszNNUjDU|NpW0GQR1XS
NCI-H2107NF\seIZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NY\OdHJPUUN3ME2xMlAyQDV2IN88US=>NF;WS49USU6JRWK=
LB996-RCCM2HNT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mk\5TWM2OD1zLkC4NFUyKM7:TR?=NGm5ZW5USU6JRWK=
NCI-H1395NHvCdmhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHfDcHVKSzVyPUGuNVA3PyEQvF2=NXHoXHJDW0GQR1XS
CHP-126M1nqXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1vadWlEPTB;MT6xOlE6QSEQvF2=NFnSS2JUSU6JRWK=
NB69NYDFU4pHT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHHBcFVKSzVyPUGuNlYyPDhizszNM3HQd3NCVkeHUh?=
CAS-1MmH0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGm4UVdKSzVyPUGuN|QzOzFizszNMnnCV2FPT0WU
JVM-3NEHYUGtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGXuWIdKSzVyPUGuOFc5PTVizszNNGfHTGRUSU6JRWK=
DMS-153MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHPCcGlKSzVyPUGuOVc3PzRizszNNF7zeYdUSU6JRWK=
SK-MEL-2Mo\DS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIL2VGRKSzVyPUGuO|E4QDlizszNM1fkeXNCVkeHUh?=
NCI-H1155NEH0foNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWDJR|UxRTFwN{O2O|Yh|ryPMoXlV2FPT0WU
NCI-H1092NFvyTlRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NE\OV4RKSzVyPUGuO|YyQDJizszNM2XUSXNCVkeHUh?=
LU-165M4TKZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3v5eGlEPTB;MT64OlQ4PiEQvF2=M{fFV3NCVkeHUh?=
HL-60NICwSm9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mnq0TWM2OD1zLkm5PVA5KM7:TR?=NUDKOZRSW0GQR1XS
REHMl6wS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3zSTmlEPTB;Mj6wNFU5OiEQvF2=MWfTRW5ITVJ?
JVM-2NYXZOG5sT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlTmTWM2OD1{LkC2NVM2KM7:TR?=NWSxSGhXW0GQR1XS
MN-60NXLvblZwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYHJR|UxRTJwMUezNFgh|ryPM170NnNCVkeHUh?=
SCC-15NYL1RmJqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUHjUot2UUN3ME2yMlIxOjdizszNM2iwbXNCVkeHUh?=
SNU-C1Mn3iS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYj1UYZsUUN3ME2yMlIyOzR|IN88US=>MlKyV2FPT0WU
SK-MEL-1M2XiR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NH73bnFKSzVyPUKuN|IxPDdizszNM4DQOnNCVkeHUh?=
TGWM17xV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFLlRnVKSzVyPUKuN|UxOjdizszNM{LYd3NCVkeHUh?=
CA46Moi0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1rLPGlEPTB;Mj63OVk3PyEQvF2=MX3TRW5ITVJ?
NCI-H23M{P0bGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnHLTWM2OD1{LkiwO|kyKM7:TR?=NE\5eHBUSU6JRWK=
MMAC-SFM{LMRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIPBe4NKSzVyPUKuPFY3OjhizszNNYXrbW5PW0GQR1XS
NCI-H2171MkfES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M32w[mlEPTB;Mz6wN|Q1QCEQvF2=M3PwZ3NCVkeHUh?=
A704NF3MWnFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NH3oUYVKSzVyPUOuNVQyQTRizszNMVXTRW5ITVJ?
DBMW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUXJR|UxRTNwMkW1O|Yh|ryPM{T6RnNCVkeHUh?=
NCI-H719M3TWTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXvYWW1vUUN3ME2zMlMxOzh2IN88US=>M17qRXNCVkeHUh?=
MC-CARMmjWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIrUfndKSzVyPUOuOVQ5OTdizszNNHPoTnRUSU6JRWK=
SIMANXXScGY{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NETJfmpKSzVyPUOuOVg1OTZizszNM2nkW3NCVkeHUh?=
SW872M2nQTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVvJR|UxRTNwN{ixNFEh|ryPMl3CV2FPT0WU
HCC1187M3zscGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWLLfVlJUUN3ME2zMlc5OzF3IN88US=>MorPV2FPT0WU
EW-13NETyO4VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4W5cWlEPTB;Mz64N|QyPyEQvF2=MVPTRW5ITVJ?
NCI-SNU-1MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVHJR|UxRTRwMkG5PVkh|ryPNI\XbnNUSU6JRWK=
NCI-H226M3rsV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mli0TWM2OD12LkOzOlA3KM7:TR?=MlPZV2FPT0WU
RPMI-8866NXjCfoEyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Moi4TWM2OD12LkO2NFI6KM7:TR?=M4K3XHNCVkeHUh?=
OCI-AML2MnvkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlrLTWM2OD12LkW1NlMh|ryPMX3TRW5ITVJ?
LU-65MlHUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVLJR|UxRTRwOUOwN|Mh|ryPMnP1V2FPT0WU
SK-N-DZNEj4T3dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXXzOJFjUUN3ME21MlY{PDZ3IN88US=>MUDTRW5ITVJ?
NB14Mm[2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGHwTXhKSzVyPUWuPVcyOzVizszNNEnTR2NUSU6JRWK=
COLO-829M4Xidmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1rwUWlEPTB;Nj6zN|M2QSEQvF2=M2ixdnNCVkeHUh?=
MHH-CALL-2NFLjV3pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUTJR|UxRTZwNUG1NFgh|ryPMYTTRW5ITVJ?
NCI-H1770NEjLdm1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUTJR|UxRTZwNk[5NFQh|ryPMljDV2FPT0WU
ECC4MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYHJR|UxRTZwOEKxO|kh|ryPMoTpV2FPT0WU
A498MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MX3JR|UxRTZwOEexPVIh|ryPNYrOWI1{W0GQR1XS
DMS-79NXLrcXV5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1HYe2lEPTB;Nz6wOFUyOiEQvF2=MXvTRW5ITVJ?
P30-OHKNGX0d5hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmC3TWM2OD15LkKxPVA3KM7:TR?=MmriV2FPT0WU
D-502MGMoLqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mkn5TWM2OD15Lkm4N|Yh|ryPNGTESGZUSU6JRWK=
RCC10RGBNU\ScXkyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUjJR|UxRThwME[yPEDPxE1?MXLTRW5ITVJ?
U-698-MMYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWXJR|UxRThwMkmyNlYh|ryPNYizXVh2W0GQR1XS
BB49-HNCM1e4SGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnXCTWM2OD17LkSyNlY2KM7:TR?=NEnqVYZUSU6JRWK=
ES1NEPDcWlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVTJR|UxRTlwNki5OVYh|ryPMXzTRW5ITVJ?
MFM-223M1vi[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWX6VoZVUUN3ME2xNE46QTJ5IN88US=>NYjjbFFoW0GQR1XS
C2BBe1NILjenlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MV\JR|UxRTFzLkO1NlMh|ryPMnX5V2FPT0WU
EB2MkfwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NF7RfYxKSzVyPUGyMlY5QDFizszNNUmzS5hbW0GQR1XS
C8166NGrPfHNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUi2[GN1UUN3ME2xN{45OzB|IN88US=>MYrTRW5ITVJ?
ES3MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUXJR|UxRTF|Lkm5O|ch|ryPMnu2V2FPT0WU
NCI-H1650M2X4UGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnjkTWM2OD1zNj6zO|Y2KM7:TR?=NX3uT3U{W0GQR1XS
Mo-TMVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWLJR|UxRTF5LkSwNlkh|ryPMUXTRW5ITVJ?
NB7MlXZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MV;JR|UxRTF5Lke0Olch|ryPNFruVoxUSU6JRWK=
ES7NX3VXJlZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MW\JR|UxRTF7LkW1NFch|ryPM1nlXHNCVkeHUh?=
ES5NYLv[2ZET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHHmdWVKSzVyPUKxMlc3PzFizszNNIG4UmpUSU6JRWK=
MSTO-211HNYrMfJpiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWXZVlIzUUN3ME2yNU45QDV6IN88US=>MVfTRW5ITVJ?
U-87-MGNW\DR5c4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlPTTWM2OD1{NT6xPVY3KM7:TR?=M4fye3NCVkeHUh?=
THP-1NWD5XndUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MonoTWM2OD1{OT63NlAyKM7:TR?=NYXncHRXW0GQR1XS
NB10NILBXIJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYj4doJjUUN3ME2zNE4zPjl2IN88US=>M33vcnNCVkeHUh?=
NH-12MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1P3cWlEPTB;M{OuNlAyPyEQvF2=NXHLe3NxW0GQR1XS
COLO-824NFPjN|JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NV72SlJsUUN3ME2zOE4yODB4IN88US=>Mmj6V2FPT0WU
SKM-1NInWd3pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2\Uc2lEPTB;M{euPFQzOiEQvF2=NXzLVGFbW0GQR1XS
NCI-H1838MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGW2TWhKSzVyPUO4MlM4QTdizszNM4fNfnNCVkeHUh?=
RLM3vqVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2X3bmlEPTB;M{muNlQ4PyEQvF2=NEjOO4VUSU6JRWK=
COLO-800NWrtPI15T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2PYdmlEPTB;NECuNFc4OyEQvF2=M37QUnNCVkeHUh?=
KG-1NVPq[JdjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXrJR|UxRTRyLki5OVUh|ryPM2TGNHNCVkeHUh?=
TURM1HabGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1vUXWlEPTB;NEGuOlM6QSEQvF2=MWXTRW5ITVJ?
LNCaP-Clone-FGCM{j3U2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{T2O2lEPTB;NEGuPVAyPyEQvF2=NGq1XHVUSU6JRWK=
NCI-H322MNXvKNZBCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmHtTWM2OD12Mj61PVg1KM7:TR?=MWfTRW5ITVJ?
LNCaP MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHTaZlhKSzVyPUmxMlMhdk1?M4\oWFI2PTB3MUe0
C4-2MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUfQSIZEUUN3ME24JI5OMnniNlU2ODVzN{S=
JURKATM1TVU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGC1UJczPCCqNHz5b4ZKSzVyPUSxOk43PiCwTR?=NXrtVIRyOjR3MUm5PVU>
MOLT-4M2\Oe2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NE\qPJQzPCCqNXrTfIRJUUN3ME2yPFU{NjVibl2=NVnoUZpXOjR3MUm5PVU>
REHNGq0cndIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1S5flI1KGh?NWraUGl2UUN3ME2yPFcvPjhibl2=M{TsbVI1PTF7OUm1
NALM-6MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYXLfnNlOjRiaB?=NHKzNHVKSzVyPUO0N|MxKG6PM{PQS|I1PTF7OUm1
RS 4;11NUPiXpdyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVSyOEBpNYm1S2Z3UUN3ME21NVkvODVibl2=MViyOFUyQTl7NR?=
697NXj2UXg1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWrMOJBqOjRiaB?=NFHlUldKSzVyPUKxNFcvOSCwTR?=NGDXbG8zPDVzOUm5OS=>
SIL-ALLNH;GeXJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVOyOEBpNFHL[VRKSzVyPUG5PU44PyCwTR?=NWPBU5pEOjR3MUm5PVU>
CEMM3PGe2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFuxTYkzPCCqMlzRTWM2OD13Mj6xPEBvVQ>?M{HmU|I1PTF7OUm1
P12NVrPcZNET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIfjcXgzPCCqNV[1bIdvUUN3ME2zPU4zPyCwTR?=MnHFNlQ2OTl7OUW=
NALM-16M1PVU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXeyOEBpM{HQN2lEPTB;OU[uNlghdk1?NFjydWgzPDVzOUm5OS=>
JURKATNF3Zc|lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NV3HPZJJPDhiaB?=MX3JR|UxRTF2Lki0JI5OMlv1NlQ2OTl7OUW=
MOLT-4NY\zOFYyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4fCOVQ5KGh?NHnpOZRKSzVyPUK2MlYhdk1?NVXHcZYyOjR3MUm5PVU>
REHMYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFHtOZA1QCCqMXzJR|UxRTR2LkexJI5OM{XRdVI1PTF7OUm1
NALM-6M2fVXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGnj[ok1QCCqNF;jc2RKSzVyPUKzMlI3KG6PNULhTIo3OjR3MUm5PVU>
RS 4;11M3zkUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{\LVVQ5KGh?MXjJR|UxRTF4ND6yPEBvVQ>?M{\0OVI1PTF7OUm1
697NXXiWlJHT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVS3S3FtPDhiaB?=M2rXSmlEPTB;M{C1MlMhdk1?NG\PNoUzPDVzOUm5OS=>
SIL-ALLMn7zS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIfGRos1QCCqMo\tTWM2OD15ND62NkBvVQ>?MkXWNlQ2OTl7OUW=
CEMMoOyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3vPPFQ5KGh?MYPJR|UxRTJ2LkW1JI5OM1X3elI1PTF7OUm1
P12NYK5XVZxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVvTVGJ2PDhiaB?=NYTSbIVWUUN3ME2xPE41PiCwTR?=MWeyOFUyQTl7NR?=
NALM-16MkfpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NITE[ZQ1QCCqNIXiO|JKSzVyPU[zMlI1KG6PMlzPNlQ2OTl7OUW=
JURKATNX7hZWF2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Ml\CO|IhcA>?M{WyUGlEPTB;Mz62OUBvVQ>?MX:yOFUyQTl7NR?=
MOLT-4MkfZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4\oelczKGh?MULJR|UxRTdwM{mgcm0>MYGyOFUyQTl7NR?=
REHNH7uc5pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXS3NkBpMmHpTWM2OD1zNj6wNUBvVQ>?MXGyOFUyQTl7NR?=
NALM-6NWnV[5N1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmLIO|IhcA>?NW\5NIlTUUN3ME2xMlc5KG6PM1zwN|I1PTF7OUm1
RS 4;11MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1S3cFczKGh?MYXJR|UxRTRwM{igcm0>Mkn4NlQ2OTl7OUW=
697MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYPzd29UPzJiaB?=MWLJR|UxRTd2LkK4JI5OM1XQPFI1PTF7OUm1
SIL-ALLNInMU2pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3zqTlczKGh?MonxTWM2OD15LkKgcm0>M4jLVVI1PTF7OUm1
CEMNGH1SZNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NH[xXo44OiCqM4PPO2lEPTB;NT60NkBvVQ>?NUftWllrOjR3MUm5PVU>
P12NXrpRodDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NX61Snd2PzJiaB?=M1PlT2lEPTB;Nj6zO{BvVQ>?NVjLSpdKOjR3MUm5PVU>
NALM-16NED6RndIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Ml65O|IhcA>?NIe2d5JKSzVyPUe3Mlc{KG6PNYLzZZFYOjR3MUm5PVU>
Y79MXXBdI9xfG:|aYOgRZN{[Xl?M3\CbVEuPTBibl2=M1vmfFEzNzJ2IHi=NVPNZopzTE2VTx?=NW\PWW5ScW6mdXPl[EBieG:ydH;zbZMhf2irY3igZ4FvKGKnIHXubIFv[2WmIHL5JGhVM{\DUFI1OzZ4Nk[1
WER-Rb-1NG\Tc5lCeG:ydH;zbZMhSXO|YYm=MnrpNU02OCCwTR?=NFHIeY4yOi9{NDDoMn\TSG1UVw>?NI\JS|FqdmS3Y3XkJIFxd3C2b4Ppd{B4cGmlaDDjZY4h[mViZX7oZY5k\WRiYomgTHQ>NVLoW|VPOjR|Nk[2OlU>
G7M2rMVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NV\2cWV4UUN3ME2zMlMhdk1?MWKyOFIxPDd|Mx?=
G166NIHqfHdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnrnTWM2OD15LkCgcm0>NXXSWZIxOjR{MES3N|M>
CB660M3\PNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUnBSnZ[UUN3ME22MlQhdk1?NILWOIIzPDJyNEezNy=>
CB1117NID4SWZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEf6TYpKSzVyPUG1MlYhdk1?M{XTWlI1OjB2N{Oz
KB-3-1Mn7BS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWnJR|UxRTFwNEigxtEhOC53MzDuUS=>M3r4bVI{QTZ{NES1
KB-8-5-11NHLOPHBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NULyT41vUUN3ME21MlAyKMLzIEKuNFEhdk1?MkjDNlM6PjJ2NEW=
KB-C-1MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWnJR|UxRTF4Lke2JOKyKDRwNUGgcm0>NYfMO|k{OjN7NkK0OFU>
KB-V-1M33re2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MX;JR|UxRTJ6MT6yOEDDuSB|MT61O{BvVQ>?NUO4[HQzOjN7NkK0OFU>
OVCAR-8MoDNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmC3TWM2OD15LkG5JOKyKDNwNkCgcm0>MVOyN|k3OjR2NR?=
NCI-ADR-RESM4G0NWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWLJR|UxRTF{N{OuN|AhyrFiMUmxMlIxKG6PM{DlWFI{QTZ{NES1
MCF7Mlu4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWjJR|UxRTVwMUGgxtEhOS52NzDuUS=>NF30PGczOzl4MkS0OS=>
MCF7-FLV1000NH;GWJhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MX7JR|UxRTN7Mz6xPEDDuSB5ND64N{BvVQ>?NFPkVnEzOzl4MkS0OS=>
S1M3TrNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NH;KTpRKSzVyPUK0MlMxKMLzIESuO|Uhdk1?NIHqRmszOzl4MkS0OS=>
S1-M1-80NFXGW4JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2PNXGlEPTB;Mk[xMlA3KMLzIES4MlI2KG6PM3fiWVI{QTZ{NES1
CORL-23/PNY\F[Jd1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2XkOGlEPTB;ND6zPEDDuSBzLkK1JI5ONFzDeHczOzl4MkS0OS=>
CORL-23/RNF2xd|hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXjJR|UxRTVwMU[gxtEhOS56MzDuUS=>M{LB[lI{QTZ{NES1
NIH3T3MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXXMOFMyUUN3ME20NE43OCEEsTC0Mlk4KG6PNXfDUo9nOjN7NkK0OFU>
NIH3T3-G185MoXtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmnITWM2OD1{NEGzMlQxKMLzIESyN{43PiCwTR?=NInBU|IzOzl4MkS0OS=>
pcDNA-HEK293MnzlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXz0c4cxUUN3ME2yMlc2KMLzIECuOlchdk1?NEjhfIMzOzl4MkS0OS=>
MDR19-HEK293MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NEfiSoVKSzVyPUi1MlUxKMLzIEGzMlY4KG6PMVGyN|k3OjR2NR?=
R482-HEK293Mlq3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUHoVWZMUUN3ME2yOU46PyEEsTC0Mlk2KG6PMmnXNlM6PjJ2NEW=
MRP1-HEK293M1joVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUDJR|UxRTJwOUmgxtEhOS52OTDuUS=>MlfRNlM6PjJ2NEW=
SF188MlH3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlHVNVAuOTByIH7NMnu0NlQuQTZiaB?=MV;EUXNQMWnpcohq[mm2czDj[YxtKGe{b4f0bEBqdiCkb4ToJJRqdWVvIHHu[EBkd26lZX70doF1cW:wLTDk[ZBm\GWwdDDtZY5v\XJ?Mn;6NlM5QDd4NEW=
T98GNWftVXRIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUixNE0yODBibl2=NIHoSWozPC17NjDoNXztbppuTE2VTx?=M4PKNYlvcGmkaYTzJINmdGxiZ4Lve5RpKGmwIHPvcoNmdnS{YYTpc44uKGSncHXk[Y51KG2jbn7ldi=>MXKyN|g5PzZ2NR?=
DU145M4nrOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NH3ncZJFVVORNILyZmtKSzVy4pk8OlAhdk1?M{nBVFI{QDh2NEK4
LNCaP NUS0eHdqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MY\EUXNQM2nzeGlEPTEkiMy3OUBvVQ>?Mn7FNlM5QDR2Mki=
PC3NUDyU4lpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVvHUINFTE2VTx?=NEnKXm1KSzVy4pk8NVc2KG6PM4LVSlI{QDh2NEK4
RT4M2fRdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmLXTWM2OD1{Nz6yNUBvVQ>?MVyyN|c6OjZ|OR?=
5637NVLUdFBZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFTwR2lKSzVyPUS1MlQ4KG6PM4\Tb|I{Pzl{NkO5
T24MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{XORmlEPTB;N{muNVIhdk1?NI\RNZozOzd7Mk[zPS=>
MCF7 NYH6fZd[TnWwY4Tpc44hSXO|YYm=M3LCcFExOCCwTR?=M3TGNFEhcA>?M2HKbmROW09?NWD6d3FGemWmdXPld{B1cGViaX7keYN1cW:wIH;mxsBIemWkMT|CpHNoczFuwrDQd|ItyqCVZYLwbY5iOyxiYX7kxsBYcXOyMh?=NVTLUWozOjN5N{CyOFQ>
KB-V1 NXHRdpdbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MoXrTWM2OD1|LkmyJO69VQ>?NVf2dWQxOjN3OUOxPVY>
Hec50coMmW1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWnJR|UxRTVibl2=MXyyN|E1PjZ6Nx?=
MDA-MB-468MYDBdI9xfG:|aYOgRZN{[Xl?M1\5Z|EwPS9zMDDuUS=>MXqyOE81QC95MjDoMWjEUXNQMWjpcoR2[2W|IHHwc5B1d3OrczDpckBiKGSxc3Wt[IVx\W6mZX70JI1idm6nch?=NF;YeFgzOzF2NEK5OC=>
MCF10AMkexRZBweHSxc3nzJGF{e2G7NYPVU|ZrOS93L{GwJI5OMkXINlQwPDhxN{KgbC=>MWfEUXNQMoKzbY5lfWOnczDhdI9xfG:|aYOgbY4h[SCmb4PlMYRmeGWwZHXueEBu[W6wZYK=MUWyN|E1PDJ7NB?=
Huh-7NHnPXWFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEPhe2IyNzFyL{GwNE8yODByIH7NNF;GSFE1QCCqNFOyT2pl\WO{ZXHz[ZMhfGinIHPlcIwhfmmjYnnsbZR6KGSxc3Wt[IVx\W6mZX70cJk>NY[5W|ZjOjJ5NEW1PFc>
Daoy NYr4TllpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFqxPVMyNjh5NT2yOFAhdk1?MlPhO|IhcA>?Ml3GSG1UVw>?MUXJR|UxRTVibl2=NWrYe|N{OjJ|OUCyO|k>
ONS-76NXTsUWtyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXuxMlg4PS1{NECgcm0>MWS3NkBpMVrEUXNQMWXJR|UxRTdwNTDuUS=>MkPGNlI{QTB{N{m=
SUM 149NXPHOZpoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWWwMVExOCCwTR?=MUW3NkBpMWjpcohq[mm2czD0bIUh[2WubDD2bYFjcWyrdImgbY4h[SCmb4PlMYRmeGWwZHXueEBu[W6wYYK=M1ryTFIzOzB7OUO5
MDA-MB-231MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXzSOmo2OC1zMECgcm0>MlGzO|IhcA>?MWrpcohq[mm2czD0bIUh[2WubDD2bYFjcWyrdImgbY4h[SCmb4PlMYRmeGWwZHXueEBu[W6wYYK=MV:yNlMxQTl|OR?=
HR5NYTFUVBPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NV7VU2dXOC1zMECgcm0>NYr1N|IzPzJiaB?=MkfCbY5pcWKrdIOgeIhmKGOnbHygeoli[mmuaYT5JIlvKGFiZH;z[U1l\XCnbnTlcpQhdWGwbnHyNFTZdXgzOjNyOUmzPS=>
BT-474-M1NWD5c2RvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MojuNE0yODBibl2=NUXOZ4FSPzJiaB?=MYLpcohq[mm2czD0bIUh[2WubDD2bYFjcWyrdImgbY4h[SCmb4PlMYRmeGWwZHXueEBu[W6wYYK=MnXuNlI{ODl7M{m=
AU565MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NULrWFg6OC1zMECgcm0>MmDIO|IhcA>?MWPpcohq[mm2czD0bIUh[2WubDD2bYFjcWyrdImgbY4h[SCmb4PlMYRmeGWwZHXueEBu[W6wYYK=MYeyNlMxQTl|OR?=
T47DNUSxdZRqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NX;Hd3NCOC1zMECgcm0>M4X5S|czKGh?NFjoXlJqdmirYnn0d{B1cGViY3XscEB3cWGkaXzpeJkhcW5iYTDkc5NmNWSncHXu[IVvfCCvYX7uZZI>MnnDNlI{ODl7M{m=
MCF7NIPMSmZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWKwMVExOCCwTR?=MnrQO|IhcA>?NILXZ2tqdmirYnn0d{B1cGViY3XscEB3cWGkaXzpeJkhcW5iYTDkc5NmNWSncHXu[IVvfCCvYX7uZZI>NYnxWlFTOjJ|MEm5N|k>
HCT116p53(+/+)NHnEXGRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{HZb|ExNTFyMECgcm0>M2jiWVI1NzR6IHi=NEDN[FVqdmirYnn0d{Bk\WyuIIDyc4xq\mW{YYTpc44h[2:vcHzleIVtgSCjdDCyOUBvVQ>?NFv3NJUzOjJ4MkG3NS=>
HCT116p53(-/-)Mn7HS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkTaNVAuOTByMDDuUS=>MmrrNlQwPDhiaB?=NE\SWW5qdmirYnn0d{Bk\WyuIIDyc4xq\mW{YYTpc44h[2:vcHzleIVtgSCjdDCyOUBvVQ>?M3TqPFIzOjZ{MUex
HeLa NXnLXWpJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NX;5d25DOTBvMUCwJI5OM{Hx[VQ5KGh?MUjEUXNQM2Pm[WlEPTB;NUKuPUBvVQ>?MYqyNlA5ODJ|NR?=
HeLa MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{\LRVExNTFyMDDuUS=>NWDP[2ZHPzJiaB?=M3PTN2ROW09?NX:5c4NFUUN3ME21NE42KG6PM{jLb|IzODhyMkO1
GBCMUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVi3NkBpNY\QRohWUUN3ME2xOE44QCCwTR?=NHHNW3IzOTl4NUezPS=>
GB-CL-1NYG3R5E6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYTJWlRjPzJiaB?=MW\JR|UxRTVwMkKgcm0>Mm\5NlE6PjV5M{m=
Mz-ChA-2NYS5ephFT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHjhenA4OiCqM3HRXGlEPTB;Mz6zNUBvVQ>?MWKyNVk3PTd|OR?=
TGBC1-TKBMnHLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUWxOFQhcA>?NFPjPXhKSzVyPU[uO|Ihdk1?MUiyNVk3PTd|OR?=
WittierM3jlSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlPaO|IhcA>?MX\JR|UxRTNwMk[gcm0>NXntVYZROjF7NkW3N|k>
H-1M4XxW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnTwO|IhcA>?MV7JR|UxRTlwNUSgcm0>NVrUc|dkOjF7NkW3N|k>
HuH-28M{PCd2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NX\he3l4PzJiaB?=MV;JR|UxRTFzLkG5JI5ONI\zd28zOTl4NUezPS=>
NECM1fzfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUO3NkBpNV3iVGd5UUN3ME25Mlk5KG6PNILueWIzOTl4NUezPS=>
REBMUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIjk[Gg4OiCqNEPNcHpKSzVyPUGzMlUyKG6PNW\tXGdHOjF7NkW3N|k>
CC-LP-1MmfqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{TzTFczKGh?NYCzc21EUUN3ME21Mlg1KG6PM3;pWFIyQTZ3N{O5
CC-SW-1Ml;NS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmHyO|IhcA>?M3LGfmlEPTB;OT61OUBvVQ>?NEj3W3kzOTl4NUezPS=>
EGI-1MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGXLUlY4OiCqMXLJR|UxRTFyLkeyJI5OMkfPNlE6PjV5M{m=
Sk-ChA-1M1\Pb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUnFRYNVPzJiaB?=M4DaXmlEPTB;MUeuNkBvVQ>?M4X0WVIyQTZ3N{O5
TFK-1NUPIZW5sT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYW3NkBpMXTJR|UxRTF|LkS1JI5OMVuyNVk3PTd|OR?=
786-ONEXPN29Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkXuOU05OCCwTR?=NIrxOog6PiCqMnvBTGNtMnvjd5VxeHKnc4Pld{B1cGVicILvcIln\XKjdHnvckBqdiCjIHTvd4Uu\GWyZX7k[Y51KG2jbn7ldkB4cXSqIFnDOVDDqH[jbIXld{Bw\iB{IITvJFIxKG6PMX[yNVY1OjN5NB?=
A498M2jJOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHq4WI82NThyIH7NMlrsPVYhcA>?MnTKTGNtNXPXeWNoe3WycILld5NmeyC2aHWgdJJwdGmoZYLheIlwdiCrbjDhJIRwe2VvZHXw[Y5l\W62IH3hco5meiC5aYToJGlEPTEEoI\hcJVmeyCxZjCyJJRwKDJyIH7NM{XXWFIyPjR{M{e0
ACHNNXTpUng6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXr2No9uPS16MDDuUS=>NXX0c2xCQTZiaB?=NUe4NGIxUEOuM4PvV5N2eHC{ZYPz[ZMhfGinIIDyc4xq\mW{YYTpc44hcW5iYTDkc5NmNWSncHXu[IVvfCCvYX7u[ZIhf2m2aDDJR|UxyqC4YXz1[ZMhd2ZiMjD0c{AzOCCwTR?=MV[yNVY1OjN5NB?=
Caki-1MmL2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWq1MVgxKG6PMV25OkBpNF;sOYFJS2x?MYfzeZBxemW|c3XzJJRp\SCycn;sbYZmemG2aX;uJIlvKGFiZH;z[U1l\XCnbnTlcpQhdWGwbnXyJJdqfGhiSVO1NOKhfmGudXXzJI9nKDJidH:gNlAhdk1?MmjzNlE3PDJ|N{S=
SN12CMUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4nQWVUuQDBibl2=NWj4dYtlQTZiaB?=MYPIR4w>MkDQd5VxeHKnc4Pld{B1cGVicILvcIln\XKjdHnvckBqdiCjIHTvd4Uu\GWyZX7k[Y51KG2jbn7ldkB4cXSqIFnDOVDDqH[jbIXld{Bw\iB{IITvJFIxKG6PNFfOSmMzOTZ2MkO3OC=>
HMC-1.1MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4S4dlEuOTByMDDuUS=>M{m0[FczKGh?NYjORXg5cW6qaXLpeJMhfGinIHPlcIwheHKxbHnm[ZJifGmxbjDpckBiKGSxc3Wt[IVx\W6mZX70JI1idm6nMlLuNlEzPDJzOEm=
HMC-1.2MlnwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXPPXI1JOS1zMECwJI5ONFv3fmo4OiCqNFnlU4tqdmirYnn0d{B1cGViY3XscEBxem:uaX\ldoF1cW:wIHnuJIEh\G:|ZT3k[ZBmdmSnboSgcYFvdmV?M{DjW|IyOjR{MUi5
C2NX35OZJoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnrPNU0yODByIH7NM37jWFczKGh?NEnXUJJqdmirYnn0d{B1cGViY3XscEBxem:uaX\ldoF1cW:wIHnuJIEh\G:|ZT3k[ZBmdmSnboSgcYFvdmV?NXvpb2VSOjF{NEKxPFk>
CHP-212MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWOxMVEzPSCwTR?=NVzTOW0{OjRvMUKwJIg>Mo\ybY5pcWKrdIOgeIhmKGOnbHygdJJwdGmoZYLheIlwdiCrbjDic5RpKHSrbXWtJIFv\CCmb4PlMYRmeGWwZHXueEBu[W6wZR?=NYrRVnVQOjFzNkmyOFI>
IMR-32NWfRVYluT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnvVNU0yOjVibl2=NXvlcVhqOjRvMUKwJIg>M2rjbolvcGmkaYTzJJRp\SClZXzsJJBzd2yrZnXyZZRqd25iaX6gZo91cCC2aX3lMUBidmRiZH;z[U1l\XCnbnTlcpQhdWGwbnW=NGDv[nAzOTF4OUK0Ni=>
KellyMXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4TjPVEuOTJ3IH7NNHewcJIzPC1zMkCgbC=>M1i1VolvcGmkaYTzJJRp\SClZXzsJJBzd2yrZnXyZZRqd25iaX6gZo91cCC2aX3lMUBidmRiZH;z[U1l\XCnbnTlcpQhdWGwbnW=NHzpTXMzOTF4OUK0Ni=>
SH-EPNEjPTIRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUSxMVEzPSCwTR?=MXiyOE0yOjBiaB?=MVHpcohq[mm2czD0bIUh[2WubDDwdo9tcW[ncnH0bY9vKGmwIHLveIghfGmvZT2gZY5lKGSxc3Wt[IVx\W6mZX70JI1idm6nMX2yNVE3QTJ2Mh?=
SH-SY5YNGjVZVFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4DEN|EuOTJ3IH7NMnHwNlQuOTJyIHi=MYLpcohq[mm2czD0bIUh[2WubDDwdo9tcW[ncnH0bY9vKGmwIHLveIghfGmvZT2gZY5lKGSxc3Wt[IVx\W6mZX70JI1idm6nMoj2NlEyPjl{NEK=
SK-N-ASMWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NU\BPJBEOS1zMkWgcm0>MkGyNlQuOTJyIHi=Mn7zbY5pcWKrdIOgeIhmKGOnbHygdJJwdGmoZYLheIlwdiCrbjDic5RpKHSrbXWtJIFv\CCmb4PlMYRmeGWwZHXueEBu[W6wZR?=M3njVlIyOTZ7MkSy
SK-N-BEM13j[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUnJTY13OS1zMkWgcm0>M4HHNVI1NTF{MDDoNEP4ZlBqdmirYnn0d{B1cGViY3XscEBxem:uaX\ldoF1cW:wIHnuJIJwfGhidHnt[U0h[W6mIHTvd4Uu\GWyZX7k[Y51KG2jbn7lMUmyNVE3QTJ2Mh?=
KG1MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIroNpIyNzFyL{GwNEBvVQ>?M2DyZlczKGh?NIntb49FVVORNVv1XW12cW6qaXLpeJMhfGinIHPlcIwheHKxbHnm[ZJifGmxbjDpckBjd3SqIITpcYUuKGGwZDDkc5NmNWSncHXu[IVvfCCvYX7u[S=>NGfNU|IyQTR3OEO1PC=>
U937M1XucWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGDlWJIyNzFyL{GwNEBvVQ>?M4n0VFczKGh?NEGxZYVFVVORMnnxbY5pcWKrdIOgeIhmKGOnbHygdJJwdGmoZYLheIlwdiCrbjDic5RpKHSrbXWtJIFv\CCmb4PlMYRmeGWwZHXueEBu[W6wZR?=MlXoNVk1PTh|NUi=
CAL62MoDFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVKwMlEuOTByIH7NM{XDRVczKGh?MoLCSG1UVw>?NV65eI5UTUN3ME2xMlQhdk1?NU\pd|d5OTl{MkO1OVM>
OCUT-1MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3vMelAvOS1zMECgcm0>NVKx[VduPzJiaB?=M4jjWmROW09?MYDFR|UxRTJwMzDuUS=>M1nKXlE6OjJ|NUWz
8505CM4ruZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGjp[3QxNjFvMUCwJI5OMkP4O|IhcA>?MoG4SG1UVw>?NY[wWoMyTUN3ME2zMlIhdk1?NXHxd4Q{OTl{MkO1OVM>
ACT-1M{\mbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWDhcphOOC5zLUGwNEBvVQ>?MUC3NkBpNU\TSJJOTE2VTx?=MnzISWM2OD13LkSgcm0>NXnBZW83OTl{MkO1OVM>
SW1736NFrpbYxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4PoR|AvOS1zMECgcm0>MV:3NkBpNVfjVZhJTE2VTx?=M3LwemVEPTB;NT62JI5OMlq2NVkzOjN3NUO=

... Click to View More Cell Line Experimental Data

In vivo BI 2536 given i.v. once or twice per week is highly efficacious in diverse xenograft models with acceptable tolerability by inhibiting cell proliferation through a mitotic arrest, and subsequently induction of tumor-cell death. Administration of BI 2536 at 50 mg/kg once or twice per week significantly inhibits growth of HCT 116 xenografts with T/C of 15% and 0.3%, respectively. BI 2536 treatment twice-weekly also leads to excellent tumor-growth in BxPC-3 and A549 models with T/C of 5% and 14%, respectively. [1]
Features The first potent and selective Plk1 inhibitor that induces all hallmarks of Plk1 inhibition.

Protocol(Only for Reference)

Kinase Assay: [1]

Plk1 in vitro kinase assay Recombinant human Plk1 (residues 1-603) is expressed as N-terminal, GST-tagged fusion protein with a baculoviral expression system and purified by affinity chromatography with Glutathione-agarose. Enzyme activity assays for Plk1 are performed in the presence of serially diluted BI 2536 with 20 ng of recombinant kinase and 10 μg casein from bovine milk as the substrate. Kinase reactions are performed in a final volume of 60 μL for 45 minutes at 30 °C (15 mM MgCl2, 25 mM MOPS [pH 7.0], 1 mM DTT, 1% DMSO, 7.5 mM ATP, 0.3 μCi γ-33P-ATP). Reactions are terminated by the addition of 125 μL of ice-cold 5% TCA. After transfer of the precipitates to Multi-Screen mixed ester cellulose filter plates, plates are washed with 1% TCA and quantified radiometrically. Dose-response curve is used for calculating IC50 value.

Cell Assay: [1]

Cell lines HeLa, A43, SKOV-3, HT-29, K562, A549, Saos-2, MCF7, HCT116, COLO 205, Hep G2, Raji and PC-3 cells, etc.
Concentrations Dissolved in DMSO, final concentrations ~1 μM
Incubation Time 24 and 72 hours
Method Cells are exposed to various concentrations of BI 2536 for 24, and 72 hours. Cell growth is assessed by the measurement of Alamar Blue dye conversion in a fluorescence spectrophotometer. For determining the DNA content of the cultures, cell suspensions are fixed in 80% ethanol, treated for 5 minutes with 0.25% Triton X-100 in PBS, and incubated with 0.1% RNase and 10 μg/mL propidium iodide (PI) in PBS for 20 minutes at RT. Cell-cycle profiles are determined by flow cytometric analysis.

Animal Study: [1]

Animal Models Female BomTac:NMRI-Foxn1nu mice injected subcutaneously with HCT 116, NCI-H460, or A549 cells
Formulation Formulated in hydrochloric acid (0.1 N), and diluted with 0.9% NaCl
Dosages ~50 mg/kg
Administration Injection i.v. once or twice per week

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)

SpeciesMouseRatRabbitGuinea pigHamsterDog
Weight (kg)0.020.151.80.40.0810
Body Surface Area (m2)0.0070.0250.150.050.020.5
Km factor36128520
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Rat dose (mg/kg) = mouse dose (22.4 mg/kg) ×  mouse Km(3)  = 11.2 mg/kg
rat Km(6)
1

References

[1] Steegmaier M, et al. Curr Biol, 2007, 17(4), 316-322.

[2] Nappi TC, et al. Cancer Res, 2009, 69(5), 1916-1923.

Clinical Trial Information( data from http://clinicaltrials.gov, updated on 2016-07-30)

NCT Number Recruitment Conditions Sponsor
/Collaborators
Start Date Phases
NCT00526149 Completed Breast Cancer|Endometrial Cancer|Head and Neck Cancer|Melanoma (Skin)|Ovarian Cancer|Sarcoma European Organisation for Research and Treatment of Cance  ...more European Organisation for Research and Treatment of Cancer - EORTC July 2007 Phase 2
NCT02215044 Terminated Pancreatic Neoplasms Boehringer Ingelheim June 2007 Phase 1
NCT00412880 Completed Carcinoma, Small Cell Boehringer Ingelheim January 2007 Phase 2
NCT02211833 Completed Carcinoma, Non-Small-Cell Lung Boehringer Ingelheim October 2006 Phase 1
NCT00701766 Completed Leukemia, Myeloid, Acute Boehringer Ingelheim October 2006 Phase 2

view more

Chemical Information

Download BI 2536 SDF
Molecular Weight (MW) 521.66
Formula

C28H39N7O3

CAS No. 755038-02-9
Storage 3 years -20℃powder
6 months-80℃in solvent
Synonyms N/A
Solubility (25°C) * In vitro DMSO 21 mg/mL (40.25 mM)
Ethanol 100 mg/mL (191.69 mM)
Water <1 mg/mL (<1 mM)
In vivo 30% PEG400+0.5% Tween80+5% propylene glycol 15 mg/mL
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Chemical Name (R)-4-(8-cyclopentyl-7-ethyl-5-methyl-6-oxo-5,6,7,8-tetrahydropteridin-2-ylamino)-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide

Frequently Asked Questions

  • Question 1
    We need to use BI 2536 in preclinical studies using mice, how to formulate the inhibitor for this in vivo study?

    Answer: For in vivo study, DMSO should not be more than 5% because the toxicity. You can formulated BI2536 in hydrochloric acid (0.1 N), and diluted with 0.9% NaCl for animal study according to the reference :( Supplemental Data) http://linkinghub.elsevier.com/retrieve/pii/S0960-9822(06)02671-6

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Related PLK Products

  • SBE 13 HCl

    SBE 13 HCl is a potent and selective PLK1 inhibitor with IC50 of 200 pM, >4000-fold selectivity over Aurora A kinase, Plk2 and Plk3.

  • Ro-3306

    RO-3306 is an ATP-competitive, and selective CDK1 inhibitor with Ki of 20 nM, >15-fold selectivity against a diverse panel of human kinases.

  • CCG-1423

    CCG-1423 is a specific RhoA pathway inhibitor, which inhibits SRF-mediated transcription.

  • Rigosertib (ON-01910)

    Rigosertib (ON-01910) is a non-ATP-competitive inhibitor of PLK1 with IC50 of 9 nM in a cell-free assay. It shows 30-fold greater selectivity against Plk2 and no activity to Plk3. Phase 3.

  • HMN-214

    HMN-214 is a prodrug of HMN-176, which alters the cellular spatial orientation of Plk1.

  • GSK461364

    GSK461364 inhibits purified Plk1 with Ki of 2.2 nM in a cell-free assay. It is more than 1000-fold selective against Plk2/3. Phase 1.

    Features:Demonstrates >390-fold selectivity for Plk1 relative to Plk2 and Plk3.

  • Volasertib (BI 6727)

    Volasertib (BI 6727) is a highly potent Plk1 inhibitor with IC50 of 0.87 nM in a cell-free assay. It shows 6- and 65-fold greater selectivity against Plk2 and Plk3. Phase 3.

    Features:A high volume of distribution, indicating good tissue penetration, and a long terminal half-life.

  • MLN0905

    MLN0905 is a potent inhibitor of PLK1 with IC50 of 2 nM.

  • Ro3280

    RO3280 is a potent, highly selective inhibitor of Polo-like kinase 1 (PLK1) with IC50 of 3 nM.

    Features:A selective PLK1 inhibitor. Demonstrates greater potency than BI2536. Potential use in nasopharyngeal carcinomas.

  • NMS-P937 (NMS1286937)

    NMS-P937 (NMS1286937) is an orally available, selective Polo-like Kinase 1 (PLK1) inhibitor with IC50 of 2 nM, 5000-fold selectivity over PLK2/PLK3. Phase 1.

Recently Viewed Items

Tags: buy BI 2536 | BI 2536 supplier | purchase BI 2536 | BI 2536 cost | BI 2536 manufacturer | order BI 2536 | BI 2536 distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
Contact Us